Syed Rizvi

Syed Rizvi

Auto-generated profile, based on publicly available information

Syed Rizvi

Oregon State University, Department of Pharmaceutical Science, College of Pharmacy, Portland, Oregon, United States

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VSVidhi M Shah
Vidhi M Shah
SRSyed Rizvi
Syed Rizvi
ASAlexander Charles Smith
Alexander Charles Smith
MTMotoyuki Tsuda
Motoyuki Tsuda
MKMadeline Krieger
Madeline Krieger
RSRosalie C. Sears
Rosalie C. Sears
Pancreatic cancer remains a formidable challenge due to limited treatment options and its aggressive nature. In recent years, the naturally occurring anticancer compound juglone has emerged as a potential therapeutic candidate, showing promising results in inhibiting tumor growth and inducing cancer cell apoptosis. However, concerns over its toxicity have hampered juglone’s clinical application. To address this issue, we have explored the use of polymeric micelles as a delivery system for juglone in pancreatic cancer treatment. These micelles, formulated using Poloxamer 407 and D-α-Tocopherol polyethylene glycol 1000 succinate, offer an innovative solution to enhance juglone’s therapeutic potential while minimizing toxicity. In-vitro studies have demonstrated that micelle-formulated juglone (JM) effectively decreases proliferation and migration and increases apoptosis in pancreatic cancer cell lines. Importantly, in-vivo, JM exhibited no toxicity, allowing for increased dosing frequency compared to free drug administration. In mice, JM significantly reduced tumor growth in subcutaneous xenograft and orthotopic pancreatic cancer models. Beyond its direct antitumor effects, JM treatment also influenced the tumor microenvironment. In immunocompetent mice, JM increased immune cell infiltration and decreased stromal deposition and activation markers, suggesting an immunomodulatory role. To understand JM’s mechanism of action, we conducted RNA sequencing and subsequent differential expression analysis on tumors that were treated with JM. The administration of JM treatment reduced the expression levels of the oncogenic protein MYC, thereby emphasizing its potential as a focused, therapeutic intervention. In conclusion, the polymeric micelles-mediated delivery of juglone holds excellent promise in pancreatic cancer therapy. This approach offers improved drug delivery, reduced toxicity, and enhanced therapeutic efficacy.

15 May 2011 in Sultan Qaboos University Medical Journal
Verified
Journal Article
Open access
PDF file
DJDeepali Jaju
Deepali Jaju
MDMohan B Dikshit
Mohan B Dikshit
JBJothi Balaji
Jothi Balaji
JGJyoji George
Jyoji George
SRSyed Rizvi
Syed Rizvi
OAOmar Al-Rawas
Omar Al-Rawas
Objectives: The objective of this study was to compare the effects of Pranayam breathing on respiratory muscle strength measured as maximum expiratory and inspiratory pressures (MEP and MIP) and relevant spirometry parameters in patients with chronic obstructive pulmonary disease (COPD) and in control subjects, and on the sympatho-vagal balance in both the groups. Methods: The research was performed in the Clinical Physiology Department, Sultan Qaboos University Hospital, Oman. Eleven patients (mean age 43.91 ± 20.56 yr; mean BMI 21.9 ± 5.5 kg/m2) and 6 controls (43.5 ± 14.6yr; 25.4 ± 3.2 kg/m2) learnt and practised Pranayam. Their respiratory and cardiovascular parameters were recorded. Their respiratory “well being” was noted as a visual analogue score (VAS). The respiratory parameters were expressed as a percentage change of predicted values. Results: Patients’ respiratory parameters were significantly lower than those of controls. Patients’ maximum respiratory pressures did not improve after Pranayam; however, they showed significant improvement in VAS 5.4 ± 2.4 to 7.2 ± 1.2 (P < 0.03). Controls showed significant increase in MIP after Pranayam exercises. There were no changes in other spirometry indices. Controls showed significant increase in their systolic blood pressure and stroke index after exercise. The vago-sympathetic balance shifted towards sympathetic in both patients and controls after exercise. Conclusion: The improvement in MIP in controls indicated the positive effect of Pranayam exercise; however, it may not be an adequately stressful exercise to produce changes in the respiratory parameters of COPD patients. The increase in VAS in patients suggested improvement in respiratory distress and quality of life.

29 October 2024 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
DSDani A. Szafran
Dani A. Szafran
NSNourhan A. Shams
Nourhan A. Shams
AMAntonio Montaño
Antonio Montaño
SRSyed Zaki Husain Rizvi
Syed Zaki Husain Rizvi
Adam AlaniAdam Alani
Adam Alani
SGSummer L Gibbs
Summer L Gibbs
Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer type, with >650,000 cases diagnosed annually worldwide.1,2 Surgical cancer resection remains the preferred treatment for HNSCC,3,4 where the surgeon balances two main challenges: (1) complete surgical resection and (2) preservation of nerves to reduce pain and maintain function. The most important factor for predicting long-term survival following surgery is the completeness of cancer resection.5 – 7 However, identifying tumors and normal tissues during surgery remains challenging, and positive surgical margins occur in 15% to 30% of patients, resulting in poor outcomes and additional therapy.8,9 Furthermore, additional malignancies are often present and undetected during surgery, representing the second leading cause of death in HNSCC patients.10 Secondary to cancer treatment, surgical outcomes are plagued by intraoperative nerve damage, causing lasting pain and loss of function, significantly affecting patient postoperative quality of life. Important cranial, spinal, and facial nerves are small, and translucent structures often buried within tissue, making them difficult to consistently identify and visualize, leading to nerve damage.11 – 14 As a result, a number of comorbidities, including severe pain, dysphagia, and jaw and sensory dysfunction, are experienced by >40% of patients.15 Unfortunately, achieving complete cancer resection while simultaneously preserving important nerves in the head and neck region remains difficult, where efforts to preserve normal anatomy and function limit cancer resection margins. Thus, current intraoperative cancer and nerve detection techniques, generally consisting of preoperative imaging, biopsy, intraoperative neuromonitoring, and visual inspection, fall far short of meeting the clinical need.16